SCHEDULE: BlackRock Discloses 7.8% Stake in Core Scientific

BlackRock, Inc. has reported a 7.8% beneficial ownership stake in Core Scientific, Inc., holding over 23 million shares of common stock.

Summary

• BlackRock, Inc. beneficially owns 23,299,564 shares of Core Scientific, Inc. common stock.
• This ownership represents 7.8% of the total outstanding common stock of Core Scientific, Inc.
• BlackRock holds sole voting power over 22,773,781 shares and sole dispositive power over 23,299,564 shares.
• The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Core Scientific, Inc.

Sentiment

Score: 5

Explanation: Neutral, as this is a factual report of an ownership stake, not a performance update or strategic announcement by the issuer.

Positives

• BlackRock, a prominent institutional investor, holds a significant 7.8% stake in Core Scientific, Inc., which may be interpreted as a signal of institutional confidence in the company.

Future Outlook

NA

Industry Context

This filing indicates a significant institutional investment by BlackRock in Core Scientific, Inc., a company operating in the digital asset mining sector. Such large holdings by major asset managers are common across various industries, reflecting portfolio diversification and strategic investment decisions.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by a major institutional investor like BlackRock could be viewed positively, potentially indicating confidence in the company's long-term prospects.

Key Dates

Keywords

BlackRock, Core Scientific, Beneficial Ownership, Schedule 13G, Common Stock, Institutional Investor, Ownership Disclosure, SEC Filing